TOPLINE: Quitting smoking at any age increases life expectancy, with the most significant increases observed in younger individuals. But people who quit over age 65 can...
Announcing a new publication for Acta Materia Medica journal. Elevated cellular oxidative stress is a common marker of cancer cell dysregulation caused by malignant transformation. Thioredoxin...
For patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), standard use of the more accurate intensity-modulated radiation therapy (IMRT) is recommended over the alternative...
For patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), standard use of the more accurate intensity-modulated radiation therapy (IMRT) is recommended over the alternative...
In a recent interview with The American Journal of Managed Care®, Jessica K. Paulus, ScD, senior director of real-world research, Ontada, a business of McKesson, and...
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung cancer, based on results from a...
Yasir Y. Elamin, MD (Moderator) Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology Division of Cancer Medicine The University of Texas MD Anderson Cancer Center...
The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been discovered by...
Evidence supporting the degree to which skeletal muscle mass and adipose tissue loss are predictors of poor outcomes in patients undergoing systemic therapy for advanced non-small...
Many countries with national healthcare systems or payers such as insurance companies use cost-effectiveness analyses to decide whether to cover new medicines, balancing treatment costs with...